Record Sales in Fourth Quarter 2013

Medistim delivers record sales for a quarter with MNOK 52.2 (MNOK 49.7). Sales for 2013 ended at MNOK 191 (MNOK 183.8), which is a 3.9 % growth. Operating profit (EBIT) for the quarter ended at MNOK 9.0 (MNOK 6.1). Operating profit for 2013 ended at MNOK 35.6
(MNOK 41.1). The Board suggests a dividend of NOK 0.80 per share (MNOK 1.10).

Presentations and numbers:

PDF: 4 quarter 2013
PDF: Q4 presentation 2013